MedTrace Logo

the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children

NCT02674607 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-10-25

No results posted yet for this study

Summary

The aim of this study is to evaluate the possible immunologic effects of spirulina in children with beta thalassemia.

Conditions

  • Beta Thalassemia Major

Interventions

DIETARY_SUPPLEMENT

Spirulina

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Mohamed R El-Shanshory, MD · professor of pediatrics- head of hematooncology unit of pediatric department- Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02674607 on ClinicalTrials.gov